Tezacaftor/Ivacaftor Receives FDA Approval for Patients Ages 6 and Older with Cystic Fibrosis - Pharmacy Times

Tezacaftor/Ivacaftor Receives FDA Approval for Patients Ages 6 and Older with Cystic Fibrosis  Pharmacy Times

Officials with the FDA today expanded the indication for tezacaftor/ivacaftor (Symdeko, Vertex) tablets for the treatment of pediatric patients ages 6 years and ...